Weill Cornell/Rockefeller/Sloan Kettering MST Program

项目总结 三院校医学博士项目是威尔·康奈尔医学(WCM)、洛克菲勒 以及斯隆·凯特琳癌症研究所(SKI)。它的使命是培养生物医学 研究人员：一方面，对生物医学科学有深入的了解，并掌握 当代研究技能，这将使他们能够进行基础研究，以阐明基本的 与人类疾病有关的生物过程；另一方面，以人类生物学为基础， 病理生物学和临床医学，这将使他们能够将基础研究的进展转移到 对人类疾病的理解、预防和治疗。 这三个机构经营着三个研究生院：威尔·康奈尔医学研究生院 (WCGS)，WCM和SKI的联合项目；RU的大卫·洛克菲勒研究生院；以及 Gerstner生物医学研究生院(GSK)。三所院校的医学博士课程是 成立于1991年，当时两个独立的MD-PHD项目，WCM-RU计划和WCM-WCGS 方案，共同组成了本方案。GSK于2009年成为该计划的一部分。 MSTP学员完成WCM医学博士学位的所有要求。他们在那里接受博士培训 在这三个研究机构的研究实验室，并获得博士学位从葛兰素史克，俄勒冈州大学或WCGS。 被录取的实习生将在7月初医学院开学前抵达。在前两年， 他们完成医学院的课程，选修两门为医学博士而设计的研究生课程 学生，并完成三个研究轮换(在三个不同的实验室)，然后他们适应他们的 论文实验室。当学生选择一个研究型实验室时，他们进入研究生院 他们的论文导师与此相关。研究生课程和论文的要求对所有人都是可比较的。 MD-博士生，无论他们被录取在哪所研究生院--学生可以 在任何一所研究生院交叉注册并选修课程以获得学分。在他们的研究培训结束时， 在他们为自己的论文辩护后，学生们将返回WMC完成他们的临床培训。 本申请要求提供经费，以便在年后继续在这三个机构进行医学博士培训 45(其前身WCMC-RU计划成立于1972年；1974年获得美国国立卫生研究院的资助)。在它目前的情况下 通过迭代，该计划将250多个独立研究实验室的教职员工聚集在一起。379 MD- 博士毕业于三所大学的医学博士项目及其前身；目前有137名 该项目中的学生。目前的学员来自55所本科学校。他们的平均绩点是 3.75。 94%的毕业生继续进行研究生临床培训；在完成课程的305名毕业生中 在他们的培训中，有258人(85%)在医学院、研究机构或生物技术/制药公司任职。

PROJECT SUMMARY The Tri-Institutional MD-PhD Program is a joint undertaking of Weill Cornell Medicine (WCM), The Rockefeller University (RU), and the Sloan Kettering Institute for Cancer Research (SKI). Its mission is to train biomedical investigators who: on the one hand, have advanced understanding of biomedical science and a mastery of contemporary research skills, which will allow them to undertake fundamental studies to elucidate basic biological processes pertaining to human disease; and, on the other hand, are well grounded in human biology, pathobiology and clinical medicine, which will equip them to transfer advances in basic research to the understanding, prevention, and treatment of human disease. The three institutions operate three graduate schools: Weill Cornell Graduate School of Medical Sciences (WCGS), a joint undertaking between WCM and SKI; the David Rockefeller Graduate School at RU; and the Gerstner Graduate School of Biomedical Sciences (GSK) at SKI. The Tri-Institutional MD-PhD Program was formed in 1991, when two independent MD-PhD Programs, the WCM-RU Program and the WCM-WCGS Program, were joined to form the present program. GSK became part of the Program in 2009. MSTP trainees complete all requirements for the MD degree at WCM. They receive their PhD training in research laboratories in the three research institutions and receive their PhD degree from GSK, RU or WCGS. Accepted trainees arrive in early July before the start of medical school. During the first two years in the Program they complete their medical school course, take two graduate level courses designed for MD-PhD students, and complete three research rotations (in three different laboratories) before they settle into their thesis laboratory. When the students choose a research laboratory they enroll in the graduate school with which their thesis mentor is associated. The graduate course and thesis requirements are comparable for all MD-PhD students, irrespective of the graduate school in which they are matriculated—and the students can cross register and take courses for credit in any of the graduate schools. At the end of their research training, after they have defended their thesis, the students return to complete their clinical training at WMC. The present application requests funds to continue MD-PhD training at the three institutions beyond Year 45 (the predecessor WCMC-RU Program was formed in 1972; it received NIH funding in 1974). In its current iteration, the Program brings together faculty in more than 250 independent research laboratories. 379 MD- PhDs have graduated from the Tri-Institutional MD-PhD Program and its predecessors; currently there are 137 students in the Program. The current trainees come from 55 undergraduate schools. Their average GPA is 3.75. 94% of the graduates pursue post-graduate clinical training; of the 305 graduates who have completed their training, 258 (85%) have appointments in medical schools, research institutes or biotech/pharma.